skip to Main Content
Juul says its chief executive is stepping down, accepts proposed ban on most flavored vaping products

Juul Labs, the big e-cigarette maker that is embroiled in controversy involving the rising underage use of vaping products, announced Wednesday that its chief executive officer is stepping down and will be succeeded by a top official from Altria, a part-owner of Juul.

Juul also said it will not lobby against a proposed ban, announced recently by President Trump, on most flavored vaping products. It said it is suspending all broadcast, print and digital product advertising in the United States.

Kevin Burns, Juul’s chief executive officer, is being succeeded by K.C. Crosthwaite, Altria’s senior vice president for chief strategy and growth. Crosthwaite oversaw “commercial and regulatory efforts” related to the launch in the United States of IQOS, a “heat-not-burn” alternative to cigarettes, Juul said in a news release. IQOS is made by Philip Morris International and marketed in the United States by Altria.

Altria owns a 35 percent stake in Juul.

FDA blasts Juul for illegally marketing e-cigarettes as less harmful than regular cigarettes

Juul also said it will end its “Make the Switch” campaign that FDA officials had criticized for implying that its e-cigarettes are safer than regular cigarettes. The agency has to give companies specific authorization to make such a claim.

The staff shake-up was announced by Burns and Juul co-founders James Monsees and Adam Bowen. [Read More @ The Washington Post]


This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

POSaBIT Buys Suite of Platforms (Leaf Data Systems, MJ Platform and Ample Organics) from Embattled Akerna Corp.

POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of  MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…

New York State now has 66 licensed cannabis retailers

New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…

FDA Says “No” to CBD Foods and Dietary Supplements

By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…

FDA finalizes guidance on cannabis clinical research

The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…

More Categories

Back To Top
×Close search